An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR)-positive, ...

L’association qui gère le site historique des Brouzils (Vendée) a été placée en redressement judiciaire le 27 novembre. Depuis 1987, elle fait vivre la mémoire des habitants réfugiés dans la forêt au ...

La startup chinoise DeepSeek vient de publier en open-source un modèle d'IA capable non seulement de résoudre des problèmes mathématiques de très haut niveau, mais aussi de vérifier la rigueur de son ...

Owning a meaningful position in PAR Technologies (PAR) has been frustrating. PAR is delaying the implementation on a “few million” dollars of recurring revenue to pursue a large Tier 1 opportunity.

Baron Funds, an investment management company, released its “Baron Discovery Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Year-to-date, the fund was up 10.75% ...

PAR Technology Corporation has been a stock in the portfolio since the Fund’s inception. PAR reported a Q2 2025 earnings result that disappointed investors, sending the stock down by 19% in the ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...

NEW HARTFORD, N.Y.--(BUSINESS WIRE)--PAR Technology Corporation (NYSE: PAR), a leading foodservice technology provider, today announced the launch of PAR ® AI, the new intelligence layer embedded ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...